Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109727453 | 10972745 | 3 | F | 20110615 | 20160908 | 20150331 | 20160912 | EXP | US-009507513-1503USA006865 | MERCK | 70.00 | YR | F | Y | 53.00000 | KG | 20160912 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109727453 | 10972745 | 1 | PS | FOSAMAX | ALENDRONATE SODIUM | 1 | Oral | 35 MG, QW | Y | 20560 | 35 | MG | TABLET | /wk | |||||
| 109727453 | 10972745 | 2 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, TID | 57000 | MG | Y | 0 | 500 | MG | TID | ||||
| 109727453 | 10972745 | 3 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, QAM | 57000 | MG | Y | 0 | 500 | MG | QD | ||||
| 109727453 | 10972745 | 4 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000MG, QPM | 57000 | MG | Y | 0 | QD | ||||||
| 109727453 | 10972745 | 5 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, BID | 57000 | MG | Y | 0 | 500 | MG | BID | ||||
| 109727453 | 10972745 | 6 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, TID | 57000 | MG | Y | 0 | 500 | MG | TID | ||||
| 109727453 | 10972745 | 7 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, BID | 57000 | MG | Y | 0 | 500 | MG | BID | ||||
| 109727453 | 10972745 | 8 | SS | IBUPROFEN. | IBUPROFEN | 1 | Oral | UNK UNK, TID | Y | 0 | TID | ||||||||
| 109727453 | 10972745 | 9 | SS | IBUPROFEN. | IBUPROFEN | 1 | Oral | UNK UNK, TID | Y | 0 | TID | ||||||||
| 109727453 | 10972745 | 10 | SS | IBUPROFEN. | IBUPROFEN | 1 | Oral | UNK UNK, TID | Y | 0 | TID | ||||||||
| 109727453 | 10972745 | 11 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 80 MG, QD | 15838 | MG | U | 0 | 80 | MG | QD | ||||
| 109727453 | 10972745 | 12 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 40 MG, QD | U | 0 | 40 | MG | TABLET | QD | |||||
| 109727453 | 10972745 | 13 | C | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 109727453 | 10972745 | 14 | C | CINNAMON. | CINNAMON | 1 | Oral | 500 MG, QD | U | 0 | 500 | MG | QD | ||||||
| 109727453 | 10972745 | 15 | C | CHOLECALCIFEROL | CHOLECALCIFEROL | 1 | Oral | 2000 MG, QD | U | 0 | QD | ||||||||
| 109727453 | 10972745 | 16 | C | CALCIUM (UNSPECIFIED) | CALCIUM | 1 | Oral | 600 MG, BID | U | 0 | 600 | MG | BID | ||||||
| 109727453 | 10972745 | 17 | C | OMEGA-3 ACIDS | OMEGA-3 FATTY ACIDS | 1 | Oral | 300 MG, BID | U | 0 | 300 | MG | BID | ||||||
| 109727453 | 10972745 | 18 | C | FIBER | PSYLLIUM HUSK | 1 | Oral | 2 CAPS., BID | U | 0 | CAPSULE | BID | |||||||
| 109727453 | 10972745 | 19 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109727453 | 10972745 | 1 | Osteopenia |
| 109727453 | 10972745 | 2 | Diabetes mellitus |
| 109727453 | 10972745 | 8 | Osteoarthritis |
| 109727453 | 10972745 | 9 | Rheumatoid arthritis |
| 109727453 | 10972745 | 11 | Prophylaxis |
| 109727453 | 10972745 | 12 | Dyslipidaemia |
| 109727453 | 10972745 | 13 | Hypertension |
| 109727453 | 10972745 | 14 | Routine health maintenance |
| 109727453 | 10972745 | 15 | Routine health maintenance |
| 109727453 | 10972745 | 16 | Routine health maintenance |
| 109727453 | 10972745 | 17 | Routine health maintenance |
| 109727453 | 10972745 | 18 | Routine health maintenance |
| 109727453 | 10972745 | 19 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 109727453 | 10972745 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109727453 | 10972745 | Condition aggravated | |
| 109727453 | 10972745 | Gastrooesophageal reflux disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 109727453 | 10972745 | 1 | 201010 | 20110729 | 0 | |
| 109727453 | 10972745 | 2 | 20110509 | 20110706 | 0 | |
| 109727453 | 10972745 | 3 | 20110707 | 20110708 | 0 | |
| 109727453 | 10972745 | 4 | 20110707 | 20110708 | 0 | |
| 109727453 | 10972745 | 5 | 20110709 | 20110713 | 0 | |
| 109727453 | 10972745 | 6 | 20110717 | 20110929 | 0 | |
| 109727453 | 10972745 | 7 | 20110930 | 20120812 | 0 | |
| 109727453 | 10972745 | 8 | 20101130 | 20110708 | 0 | |
| 109727453 | 10972745 | 9 | 20110806 | 20120329 | 0 | |
| 109727453 | 10972745 | 10 | 20140528 | 0 | ||
| 109727453 | 10972745 | 11 | 20101130 | 20120405 | 0 | |
| 109727453 | 10972745 | 12 | 201008 | 0 | ||
| 109727453 | 10972745 | 13 | 2008 | 0 | ||
| 109727453 | 10972745 | 14 | 2008 | 0 | ||
| 109727453 | 10972745 | 15 | 201005 | 0 | ||
| 109727453 | 10972745 | 16 | 2000 | 0 | ||
| 109727453 | 10972745 | 17 | 2009 | 0 | ||
| 109727453 | 10972745 | 18 | 200605 | 0 | ||
| 109727453 | 10972745 | 19 | 2007 | 0 |